Literature DB >> 24392196

Progress on ThermoBrachytherapy Surface Applicator for Superficial Tissue Diseases.

Kavitha Arunachalam1, Oana I Craciunescu1, Paolo F Maccarini1, Jaime L Schlorff2, Edward Markowitz2, Paul R Stauffer1.   

Abstract

This work reports the ongoing development of a combination applicator for simultaneous heating of superficial tissue disease using a 915 MHz DCC (dual concentric conductor) array and High Dose Rate (HDR) brachytherapy delivered via an integrated conformal catheter array. The progress includes engineering design changes in the waterbolus, DCC configurations and fabrication techniques of the conformal multilayer applicator. The dosimetric impact of the thin copper DCC array is also assessed. Steady state fluid dynamics of the new waterbolus bag indicates nearly uniform flow with less than 1°C variation across a large (19×32cm) bolus. Thermometry data of the torso phantom acquired with computer controlled movement of fiberoptic temperature probes inside thermal mapping catheters indicate feasibility of real time feedback control for the DCC array. MR (magnetic resonance) scans of a torso phantom indicate that the waterbolus thickness across the treatment area is controlled by the pressure applied by the surrounding inflatable airbladder and applicator securing straps. The attenuation coefficient of the DCC array was measured as 3± 0.001% and 2.95±0.03 % using an ion chamber and OneDose™ dosimeters respectively. The performance of the combination applicator on patient phantoms provides valuable feedback to optimize the applicator prior use in the patient clinic.

Entities:  

Keywords:  brachytherapy; chestwall recurrence; hyperthermia; superficial disease; thermoradiotherapy

Year:  2009        PMID: 24392196      PMCID: PMC3877330          DOI: 10.1117/12.809493

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  29 in total

1.  Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment.

Authors:  R J Myerson; W L Straube; E G Moros; B N Emami; H K Lee; C A Perez; M E Taylor
Journal:  Int J Hyperthermia       Date:  1999 Jul-Aug       Impact factor: 3.914

2.  Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.

Authors:  R Leonard; J Hardy; G van Tienhoven; S Houston; P Simmonds; M David; J Mansi
Journal:  J Clin Oncol       Date:  2001-11-01       Impact factor: 44.544

3.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.

Authors:  J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

4.  Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

Authors:  P K Sneed; P R Stauffer; M W McDermott; C J Diederich; K R Lamborn; M D Prados; S Chang; K A Weaver; L Spry; M K Malec; S A Lamb; B Voss; R L Davis; W M Wara; D A Larson; T L Phillips; P H Gutin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-15       Impact factor: 7.038

5.  Multilayer conformal applicator for microwave heating and brachytherapy treatment of superficial tissue disease.

Authors:  T Juang; P R Stauffer; D G Neuman; J L Schlorff
Journal:  Int J Hyperthermia       Date:  2006-11       Impact factor: 3.914

6.  Clinical results of irradiation combined with local hyperthermia.

Authors:  C A Perez; G Nussbaum; B Emami; D VonGerichten
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

Review 7.  Breast cancer: chest wall recurrences.

Authors:  Marie E Taylor
Journal:  Curr Treat Options Oncol       Date:  2002-04

8.  Results of irradiation in the treatment of locoregional breast cancer recurrence.

Authors:  K K Chen; E D Montague; M J Oswald
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

9.  Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a Report by the Radiation Therapy Oncology Group.

Authors:  C A Perez; B Gillespie; T Pajak; N B Hornback; B Emami; P Rubin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-03       Impact factor: 7.038

10.  Management of locoregional recurrent breast cancer.

Authors:  N A Janjan; M D McNeese; A U Buzdar; E D Montague; M J Oswald
Journal:  Cancer       Date:  1986-10-01       Impact factor: 6.860

View more
  4 in total

Review 1.  Conformal microwave array (CMA) applicators for hyperthermia of diffuse chest wall recurrence.

Authors:  Paul R Stauffer; Paolo Maccarini; Kavitha Arunachalam; Oana Craciunescu; Chris Diederich; Titania Juang; Francesca Rossetto; Jaime Schlorff; Andrew Milligan; Joe Hsu; Penny Sneed; Zeljko Vujaskovic
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

2.  Design of a water coupling bolus with improved flow distribution for multi-element superficial hyperthermia applicators.

Authors:  Kavitha Arunachalam; Paolo F Maccarini; Jaime L Schlorff; Yngve Birkelund; Svein Jacobsen; Paul R Stauffer
Journal:  Int J Hyperthermia       Date:  2009-11       Impact factor: 3.914

3.  Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer.

Authors:  Timothy M Zagar; Zeljko Vujaskovic; Silvia Formenti; Hope Rugo; Franco Muggia; Brigid O'Connor; Robert Myerson; Paul Stauffer; I-Chow Hsu; Chris Diederich; William Straube; Mary-Keara Boss; Alina Boico; Oana Craciunescu; Paolo Maccarini; David Needham; Nicholas Borys; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2014-08       Impact factor: 3.914

4.  Preclinical assessment of comfort and secure fit of thermobrachytherapy surface applicator (TBSA) on volunteer subjects.

Authors:  Kavitha Arunachalam; Oana I Craciunescu; Edward J Markewitz; Paolo F Maccarini; Jaime L Schlorff; Paul R Stauffer
Journal:  J Appl Clin Med Phys       Date:  2012-09-06       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.